CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands |
Total |
Common stock |
Additional paid-in capital |
Treasury stock |
Accumulated other comprehensive (loss) income |
Accumulated deficit |
Beginning balance (in shares) at Dec. 31, 2023 |
|
89,041,946
|
|
|
|
|
Beginning balance at Dec. 31, 2023 |
$ (148,249)
|
$ 7,312
|
$ 1,180,545
|
$ (541)
|
$ (93)
|
$ (1,335,472)
|
Treasury stock, beginning balance (in shares) at Dec. 31, 2023 |
|
|
|
(6,748,809)
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Loss for the period |
(83,150)
|
|
|
|
|
(83,150)
|
Remeasurement of defined benefit pension liability |
(81)
|
|
|
|
(81)
|
|
Foreign currency translation adjustment |
(61)
|
|
|
|
(61)
|
|
Other comprehensive income (loss) before share of other comprehensive loss in joint venture |
(142)
|
|
|
|
(142)
|
|
Share of other comprehensive loss in joint venture |
(103)
|
|
|
|
(103)
|
|
Other comprehensive income (loss) |
(245)
|
|
|
|
(245)
|
|
Total comprehensive loss |
(83,395)
|
|
|
|
(245)
|
(83,150)
|
Vestings of RSUs |
0
|
|
(42)
|
$ 42
|
|
|
Vestings of RSUs (in shares) |
|
|
|
502,929
|
|
|
Exercise of stock options |
74
|
|
72
|
$ 2
|
|
|
Exercise of options (in shares) |
|
|
|
31,988
|
|
|
Issuance of shares, underwritten offering, net of transaction costs |
60,506
|
$ 921
|
59,345
|
$ 240
|
|
|
Issuance of shares, underwritten offering, net of transaction costs (in shares) |
|
10,411,912
|
|
3,000,000
|
|
|
Issuance of warrants, underwritten offering, net of transaction costs |
36,925
|
|
36,925
|
|
|
|
Issuance of shares, 2022 Employee Stock Purchase Plan |
323
|
|
305
|
$ 18
|
|
|
Issuance of shares, 2022 Employee Stock Purchase Plan (in shares) |
|
|
|
229,675
|
|
|
Share-based compensation expense |
2,146
|
|
2,146
|
|
|
|
Common stock, increase (decrease) (in shares) |
|
10,411,912
|
|
3,764,592
|
|
|
Stockholders' equity, excluding OCI, increase (decrease) |
99,974
|
$ 921
|
98,751
|
$ 302
|
|
|
Ending balance (in shares) at Jun. 30, 2024 |
|
99,453,858
|
|
|
|
|
Ending balance at Jun. 30, 2024 |
(131,670)
|
$ 8,233
|
1,279,296
|
$ (239)
|
(338)
|
(1,418,622)
|
Treasury stock, ending balance (in shares) at Jun. 30, 2024 |
|
|
|
(2,984,217)
|
|
|
Beginning balance (in shares) at Mar. 31, 2024 |
|
89,041,946
|
|
|
|
|
Beginning balance at Mar. 31, 2024 |
(194,449)
|
$ 7,312
|
1,181,020
|
$ (502)
|
(201)
|
(1,382,078)
|
Treasury stock, beginning balance (in shares) at Mar. 31, 2024 |
|
|
|
(6,264,720)
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Loss for the period |
(36,544)
|
|
|
|
|
(36,544)
|
Remeasurement of defined benefit pension liability |
(81)
|
|
|
|
(81)
|
|
Foreign currency translation adjustment |
17
|
|
|
|
17
|
|
Other comprehensive income (loss) before share of other comprehensive loss in joint venture |
(64)
|
|
|
|
(64)
|
|
Share of other comprehensive loss in joint venture |
(73)
|
|
|
|
(73)
|
|
Other comprehensive income (loss) |
(137)
|
|
|
|
(137)
|
|
Total comprehensive loss |
(36,681)
|
|
|
|
(137)
|
(36,544)
|
Vestings of RSUs |
0
|
|
(22)
|
$ 22
|
|
|
Vestings of RSUs (in shares) |
|
|
|
254,899
|
|
|
Exercise of stock options |
41
|
|
40
|
$ 1
|
|
|
Exercise of options (in shares) |
|
|
|
25,604
|
|
|
Issuance of shares, underwritten offering, net of transaction costs |
60,506
|
$ 921
|
59,345
|
$ 240
|
|
|
Issuance of shares, underwritten offering, net of transaction costs (in shares) |
|
10,411,912
|
|
3,000,000
|
|
|
Issuance of warrants, underwritten offering, net of transaction costs |
36,925
|
|
36,925
|
|
|
|
Share-based compensation expense |
1,988
|
|
1,988
|
|
|
|
Common stock, increase (decrease) (in shares) |
|
10,411,912
|
|
3,280,503
|
|
|
Stockholders' equity, excluding OCI, increase (decrease) |
99,460
|
$ 921
|
98,276
|
$ 263
|
|
|
Ending balance (in shares) at Jun. 30, 2024 |
|
99,453,858
|
|
|
|
|
Ending balance at Jun. 30, 2024 |
$ (131,670)
|
$ 8,233
|
1,279,296
|
$ (239)
|
(338)
|
(1,418,622)
|
Treasury stock, ending balance (in shares) at Jun. 30, 2024 |
|
|
|
(2,984,217)
|
|
|
Beginning balance (in shares) at Dec. 31, 2024 |
98,861,402
|
101,606,376
|
|
|
|
|
Beginning balance at Dec. 31, 2024 |
$ (202,642)
|
$ 8,425
|
1,283,892
|
$ (220)
|
(1,421)
|
(1,493,318)
|
Treasury stock, beginning balance (in shares) at Dec. 31, 2024 |
(2,744,974)
|
|
|
(2,744,974)
|
|
|
Ending balance (in shares) at Mar. 31, 2025 |
|
101,759,684
|
|
|
|
|
Ending balance at Mar. 31, 2025 |
$ (238,223)
|
$ 8,439
|
1,286,557
|
$ (207)
|
(1,092)
|
(1,531,920)
|
Treasury stock, ending balance (in shares) at Mar. 31, 2025 |
|
|
|
(2,581,398)
|
|
|
Beginning balance (in shares) at Dec. 31, 2024 |
98,861,402
|
101,606,376
|
|
|
|
|
Beginning balance at Dec. 31, 2024 |
$ (202,642)
|
$ 8,425
|
1,283,892
|
$ (220)
|
(1,421)
|
(1,493,318)
|
Treasury stock, beginning balance (in shares) at Dec. 31, 2024 |
(2,744,974)
|
|
|
(2,744,974)
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Loss for the period |
$ (95,248)
|
|
|
|
|
(95,248)
|
Remeasurement of defined benefit pension liability |
(88)
|
|
|
|
(88)
|
|
Foreign currency translation adjustment |
1,121
|
|
|
|
1,121
|
|
Other comprehensive income (loss) before share of other comprehensive loss in joint venture |
1,033
|
|
|
|
1,033
|
|
Share of other comprehensive loss in joint venture |
0
|
|
|
|
|
|
Other comprehensive income (loss) |
1,033
|
|
|
|
1,033
|
|
Total comprehensive loss |
(94,215)
|
|
|
|
1,033
|
(95,248)
|
Vestings of RSUs |
0
|
$ 41
|
(41)
|
|
|
|
Vestings of RSUs (in shares) |
|
424,379
|
|
|
|
|
Exercise of stock options |
$ 34
|
$ 2
|
32
|
|
|
|
Exercise of options (in shares) |
18,565
|
18,565
|
|
|
|
|
Issuance of shares, underwritten offering, net of transaction costs |
$ 42,376
|
$ 1,285
|
41,091
|
|
|
|
Issuance of shares, underwritten offering, net of transaction costs (in shares) |
|
13,031,161
|
|
|
|
|
Issuance of warrants, underwritten offering, net of transaction costs |
50,760
|
|
50,760
|
|
|
|
Issuance of shares, 2022 Employee Stock Purchase Plan |
271
|
|
258
|
$ 13
|
|
|
Issuance of shares, 2022 Employee Stock Purchase Plan (in shares) |
|
|
|
163,576
|
|
|
Share-based compensation expense |
4,232
|
|
4,232
|
|
|
|
Common stock, increase (decrease) (in shares) |
|
13,474,105
|
|
163,576
|
|
|
Stockholders' equity, excluding OCI, increase (decrease) |
$ 97,673
|
$ 1,328
|
96,332
|
$ 13
|
|
|
Ending balance (in shares) at Jun. 30, 2025 |
112,499,083
|
115,080,481
|
|
|
|
|
Ending balance at Jun. 30, 2025 |
$ (199,184)
|
$ 9,753
|
1,380,224
|
$ (207)
|
(388)
|
(1,588,566)
|
Treasury stock, ending balance (in shares) at Jun. 30, 2025 |
(2,581,398)
|
|
|
(2,581,398)
|
|
|
Beginning balance (in shares) at Mar. 31, 2025 |
|
101,759,684
|
|
|
|
|
Beginning balance at Mar. 31, 2025 |
$ (238,223)
|
$ 8,439
|
1,286,557
|
$ (207)
|
(1,092)
|
(1,531,920)
|
Treasury stock, beginning balance (in shares) at Mar. 31, 2025 |
|
|
|
(2,581,398)
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
Loss for the period |
(56,646)
|
|
|
|
|
(56,646)
|
Remeasurement of defined benefit pension liability |
(46)
|
|
|
|
(46)
|
|
Foreign currency translation adjustment |
750
|
|
|
|
750
|
|
Other comprehensive income (loss) before share of other comprehensive loss in joint venture |
704
|
|
|
|
704
|
|
Share of other comprehensive loss in joint venture |
0
|
|
|
|
|
|
Other comprehensive income (loss) |
704
|
|
|
|
704
|
|
Total comprehensive loss |
(55,942)
|
|
|
|
704
|
(56,646)
|
Vestings of RSUs |
0
|
$ 27
|
(27)
|
|
|
|
Vestings of RSUs (in shares) |
|
271,071
|
|
|
|
|
Exercise of stock options |
34
|
$ 2
|
32
|
|
|
|
Exercise of options (in shares) |
|
18,565
|
|
|
|
|
Issuance of shares, underwritten offering, net of transaction costs |
42,376
|
$ 1,285
|
41,091
|
|
|
|
Issuance of shares, underwritten offering, net of transaction costs (in shares) |
|
13,031,161
|
|
|
|
|
Issuance of warrants, underwritten offering, net of transaction costs |
50,760
|
|
50,760
|
|
|
|
Share-based compensation expense |
1,811
|
|
1,811
|
|
|
|
Common stock, increase (decrease) (in shares) |
|
13,320,797
|
|
0
|
|
|
Stockholders' equity, excluding OCI, increase (decrease) |
$ 94,981
|
$ 1,314
|
93,667
|
$ 0
|
|
|
Ending balance (in shares) at Jun. 30, 2025 |
112,499,083
|
115,080,481
|
|
|
|
|
Ending balance at Jun. 30, 2025 |
$ (199,184)
|
$ 9,753
|
$ 1,380,224
|
$ (207)
|
$ (388)
|
$ (1,588,566)
|
Treasury stock, ending balance (in shares) at Jun. 30, 2025 |
(2,581,398)
|
|
|
(2,581,398)
|
|
|